Tag

Us Food And Drug Administration

All articles tagged with #us food and drug administration

FDA flags Whole Foods guacamole recall as highest risk amid salmonella fears
health5 days ago

FDA flags Whole Foods guacamole recall as highest risk amid salmonella fears

The FDA has classified a recall of Whole Foods Mild Guacamole Dip as Class I, its highest risk, due to possible salmonella contamination from jalapeños. About 12,995 units sold in 12 states (dates Aug. 7–12) were produced in Akron, Ohio, and Austin, Texas. Consumers should discard the product and seek refunds. The recall is tied to a broader multistate jalapeño outbreak; hundreds have been sickened nationwide, though no illnesses from these recalled guacamole products have been reported.

FDA clears blood test that flags brain amyloid for Alzheimer’s diagnosis
health10 days ago

FDA clears blood test that flags brain amyloid for Alzheimer’s diagnosis

The FDA has approved Roche’s blood test that detects brain amyloid, a biomarker for Alzheimer’s disease, to help diagnose suspected cases. It is not intended for routine screening and could be easier to administer in primary care than PET scans or cerebrospinal fluid tests, potentially enabling earlier, less invasive confirmation for patients and families.

Thyroid tablet recall flags potential overpotency; check your lot
health10 days ago

Thyroid tablet recall flags potential overpotency; check your lot

Vitruvias Therapeutics is recalling one lot of its 30 mg Thyroid Tablets, USP after FDA testing found the batch could be superpotent, potentially causing hyperthyroid symptoms such as weight loss, heat intolerance, fatigue and hypertension. The recalled product is labeled Thyroid Tablets, USP with expiration Sept. 30, 2026 and National Drug Code 69680-166-00, lot number 504950, distributed nationwide Jan. 31–Sept. 30, 2025; about 3,600 units were released (roughly 1,900 sold). Those taking the medication should not stop without consulting their healthcare provider; contact Vitruvias Safety at [email protected] or 256-239-9373. No adverse events have been reported to date.

FDA panel greenlights broader access to six controversial peptides
health1 month ago

FDA panel greenlights broader access to six controversial peptides

An FDA Pharmacy Compounding Advisory Committee voted to recommend loosening regulations on six peptide therapies—BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500—potentially enabling prescription-based access if the FDA approves; supporters hail a win for personalized medicine, but FDA scientists have warned there isn’t enough data on safety and efficacy, and a final decision could take months.

Salmonella recall hits six states as 1.5 million dozen eggs are pulled from shelves
health1 month ago

Salmonella recall hits six states as 1.5 million dozen eggs are pulled from shelves

Approximately 1.5 million dozen white and brown cage-free eggs from Midwest Poultry Services have been recalled for potential Salmonella contamination, sold at Brookshire Grocery stores in Texas, Louisiana, Oklahoma, Arkansas, New Mexico and Mississippi and Kroger stores in Texas and Louisiana. Sell-by dates range from July 20 to August 17. Look for codes P-1950 or 0840962 and Julian dates 157–184 to identify affected eggs. Consumers who bought these eggs should discard them or return them, and monitor for symptoms of Salmonella infection.

Lettuce safety under spotlight as cyclosporiasis outbreak expands
health1 month ago

Lettuce safety under spotlight as cyclosporiasis outbreak expands

An ongoing cyclosporiasis outbreak linked to Taylor Farms iceberg lettuce has sickened more than 7,000 people nationwide. Despite a Taylor Farms recall and Sysco halting distribution from Mexico, investigators are still determining the source, while health authorities urge consumers to avoid recalled lettuce, check packaging details, and follow FDA/CDC guidance as the investigation continues.

Trump-backed push to insert AI doctors into US medicine faces safety questions
technology3 months ago

Trump-backed push to insert AI doctors into US medicine faces safety questions

The Trump administration is laying groundwork for chatbots that can diagnose illness and prescribe medicine, hoping to address doctor shortages, but physicians warn AI could bring safety, liability and bias concerns. A Washington Post story highlights a real case where a patient’s AI-assisted diagnosis led to a clinical-trial entry, illustrating AI’s potential to augment care alongside significant regulatory and safety challenges.

Court reinstates in-person pickup for abortion pills nationwide (temporary)
health4 months ago

Court reinstates in-person pickup for abortion pills nationwide (temporary)

A federal appeals court temporarily reinstated the rule that abortion pills must be picked up in person, blocking access via mail and telehealth. The decision, tied to Louisiana’s suit against the FDA, is a win for antiabortion advocates and will affect access in states with bans while manufacturers seek to pause or challenge the ruling.

Supplements aren’t a cancer shield, warns an oncologist
health7 months ago

Supplements aren’t a cancer shield, warns an oncologist

An oncologist notes that while most dietary supplements aren’t harmful, some—particularly antioxidants for immunocompromised patients—should be used with caution. There’s no clear evidence that supplements prevent cancer, and their use can raise safety and interaction concerns with cancer therapies; patients should discuss any supplement plan with their clinician and be mindful of regulatory and safety considerations.